ClassID:

109111

C12N15/869 - CPC Classification

Classification description:

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression; Vectors or expression systems specially adapted for eukaryotic hosts for animal cells; Viral vectors Herpesviral vectors

Recent Application in this class:
#1
20250333766
2025-10-30

RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF

#2
20240156927
2024-05-16

METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT

#3
20230175017
2023-06-08

RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF

#4
20220332780
2022-10-20

CA2-IL15 FUSION PROTEINS FOR TUNABLE REGULATION

#5
20220213161
2022-07-07

MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREATING TUMOURS

#6
20210386838
2021-12-16

Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

#7
20210069248
2021-03-11

CA2 compositions and methods for tunable regulation

#8
20210010033
2021-01-14

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

#9
20210009952
2021-01-14

Method for activating T cells for cancer treatment

#10
20200289630
2020-09-17

Method for activating T cells for cancer treatment

#11
20190249196
2019-08-15

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

#12
20190099479
2019-04-04

Recombinant HCMV and RHCMV vectors and uses thereof

#13
20190010200
2019-01-10

Modified interleukin 12 and use thereof in preparing drugs for treating tumours

#14
20180363006
2018-12-20

Turkey herpesvirus vectored recombinant containing avian influenza genes

#15
20180326025
2018-11-15

Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

#16
20180271974
2018-09-27

Herpes simplex virus type-1(HSV-1) vaccine strain VC2 generating an anti-EHV-1 immune response

#17
20180163230
2018-06-14

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

#18
20180142260
2018-05-24

Promoters for expression of heterologous genes

#19
20180002723
2018-01-04

Retargeted herpesvirus with a glycoprotein H fusion

#20
20170298389
2017-10-19

HSV VACCINES

#21
20170298386
2017-10-19

Turkey herpesvirus vectored recombinant containing avian influenza genes

#22
20170165336
2017-06-15

Methods and compositions for transgene expression in a herpesvirus vector system

#23
20160114027
2016-04-28

Recombinant HCMV and RHCMV vectors and uses thereof

#24
20150139954
2015-05-21

Recombinant herpes virus and pharmaceutical composition containing the same

#25
20140314811
2014-10-23

Herpes simplex virus vaccines

#26
20130230556
2013-09-05

Herpesvirus of turkeys vectored vaccine against avian influenza in poultry

#27
20130136768
2013-05-30

Recombinant HCMV and RHCMV vectors and uses thereof

#28
20130071355
2013-03-21

Recombinant herpes virus and pharmaceutical composition containing the same

#29
20120321599
2012-12-20

Herpes virus strains

#30
20120263752
2012-10-18

Herpes simplex virus vaccines

#31
20120164108
2012-06-28

VIRUS STRAINS

#32
20100092510
2010-04-15

Turkey herpesvirus vectored recombinant containing avian influenza genes

#33
20090220460
2009-09-03

VIRUS STRAINS

#34
20090176203
2009-07-09

Mutant HSV, materials and methods for generation of mutant HSV

#35
20080241188
2008-10-02

Turkey herpesvirus vectored recombinant containing avian influenza genes

#36
20070264282
2007-11-15

Herpes virus strains for gene therapy

#37
20070003571
2007-01-04

Virus strains